ABVC
Abvc Biopharma
$1.02
−$0.13 (−11.3%)Jul 27, 2026
Key metrics
The numbers that frame ABVC today
- Market cap
- $26.52M
- P/E (TTM)
- -3.1
- EV / FCF
- -8.7
- ROIC
- -56.3%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $0.90
- 52wk High
- $3.40
Growth
Revenue and earnings trend for ABVC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ABVC
Is Abvc Biopharma a good buy?
No. Abvc Biopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Abvc Biopharma is selling at a very high price.
What is the market capitalization of ABVC?
Abvc Biopharma's market capitalization is $26.52M.
What is the P/E ratio for ABVC stock?
Abvc Biopharma's current P/E ratio is -3.1.
What is the 52-week high for ABVC stock?
The 52-week high for Abvc Biopharma is $3.40. The current close of $1.02 is 70% below that high.
What is the 52-week low for ABVC stock?
The 52-week low for Abvc Biopharma is $0.90. The current close of $1.02 is 13.3% above that low.
Does ABVC stock pay dividends?
Abvc Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ABVC?
Abvc Biopharma's Debt / Equity ratio is 0.25.